Podcasts about Drug policy

In this episode, Dr Elle Wadsworth talks to Dr Amy Peacock, an Associate Professor and Deputy Director of the National Drug and Alcohol Research Centre, University of New South Wales, and Dr Krista Siefried, a Clinical Research Lead and Deputy Director, of the National Centre for Clinical Research on Emerging Drugs at the University of New South Wales, Australia. The interview covers two research articles: 1) Amy's article on trends in gamma-hydroxybutyrate (GHB) use, harms and treatment in Australia and 2) Krista's article on emergency department presentations, hospitalisations and police seizure data related to GHB in New South Wales, Australia.What is GHB? [01:30]Why is GHB an important drug to examine in the Australian population [02:30]The data sources Amy used in her study [04:20] The data sources Krista used in her study [06:45]The key findings of the study [08:21]Metabolites of GHB and risks of consuming GHB with alcohol [13:20]The implications of the findings for policy and treatment in Australia [14:04]The reasons behind the recent increase of GHB in Australia [16:30]The take home messages [19:14]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group, and her research interests include drug policy, cannabis legalisation, and public health. Elle holds voluntary roles at The Loop, a non-profit service provider of drug checking in the UK and the International Society for the Study of Drug Policy. About Amy Peacock: Amy is an Associate Professor, National Health and Medical Research Council (NHMRC) Emerging Leadership Fellow and Deputy Director of the National Drug and Alcohol Research Centre, University of New South Wales. She is also Program Lead for Drug Trends, a national monitoring system identifying trends in illicit drug use, markets and harms that is funded by the Australian Government Department of Health, Disability and Ageing.About Krista Siefried: Krista is Clinical Research Lead and Deputy Director, the National Centre for Clinical Research on Emerging Drugs (NCCRED) at the University of New South Wales (UNSW) in Sydney, Australia. She is also a Senior Lecturer at the UNSW National Drug and Alcohol Research Centre (NDARC), and St Vincent's Hospital Sydney Alcohol and Drug Service. Krista works towards evidence-based interventions to reduce harm and improve healthcare for people who use drugs. Her leadership emphasises collaborative research, deep community engagement, and practical outcomes to address the needs of individuals, families, and frontline service providers.Declarations of interest: Krista is employed by the UNSW and St Vincent's Health Network Sydney, she has no other conflicts to declare. Original articles: Emergency department presentations, hospitalisations and police seizure data related to gamma-hydroxybutyrate (GHB) in New South Wales, Australia, from 2015 to 2024 https://doi.org/10.1111/add.70202 Trends in gamma-hydroxybutyrate use, harms and treatment in Australia, 2013 to 2024 https://doi.org/10.1111/add.70308The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information. Hosted on Acast. See acast.com/privacy for more information.

News, Czech government tightenes drug policy, Zdena Mašínová obituary, Victoriia Kralko, author of award-winning audio series Hovory

News, Czech government tightenes drug policy, Zdena Mašínová obituary, Victoriia Kralko, author of award-winning audio series Hovory

Juan Vargas talks about the unintended consequences of an anti-drug policy in Colombia. "The Rise and Persistence of Illegal Crops: Evidence from a Naive Policy Announcement" by Mounu Prem, Juan F. Vargas, and Daniel Mejía. OTHER RESEARCH WE DISCUSS IN THIS EPISODE: “Inside the war on drugs: Effectiveness and unintended consequences of a large illicit crops eradication program in Colombia" by Alberto Abadie, Maria C. Acevedo, Maurice Kugler, and Juan Vargas. “Estimating the causal effect of forced eradication on coca cultivation in Colombian municipalities" by Luis Carlos Reyes. “On the effects of enforcement on illegal markets: Evidence from a quasi-experiment in Colombia" by Daniel Mejía, Pascual Restrepo, and Sandra V. Rozo. “Bushes and bullets: Illegal cocaine markets and violence in Colombia" by Daniel Mejía and Pascual Restrepo. “Rural windfall or a new resource curse? Coca, income, and civil conflict in Colombia" by Joshua D. Angrist and Adriana D. Kugler. “A geography of illicit crops (coca leaf) and armed conflict in Colombia" by Ana María Díaz and Fabio Sánchez. “The health consequences of aerial spraying illicit crops: The case of Colombia" by Adriana Camacho and Daniel Mejía. “Deforestation and Coca Cultivation Rooted in Twentieth-Century Development Projects" by Liliana M. Dávalos, Karina M. Sanchez, and Dolors Armenteras. "Making a Narco: Childhood Exposure to Illegal Labor Markets and Criminal Life Paths" by Maria Micaela Sviatschi. "Coca-Based Local Growth and Its Socio-Economic Impact in Colombia" by Lucas Marín Llanes, Manuel Fernández Sierra, María Alejandra Vélez, Eduard F. Martínez-González, and Paulo Jose Murillo-Sandoval. "Cocaine Goes Bananas: Global Spillovers from an Illicit Supply Shock" by Gianmarco Daniele, Adam Soliman, and Juan F. Vargas. Want more? Check out my new book! The Science of Second Chances: A Revolution in Criminal Justice is available now. I have a Substack! Sign up for Probable Causation: The Newsletter.

Hosts Kaycee McIntosh and Julie Henningsen recount Finnish corporal Aimo Koivunen's March 18, 1944 ordeal during the Continuation War: leading a seven-man long-range ski reconnaissance patrol in Soviet-controlled Lapland at −20°C, he collapses under exhaustion during a Soviet encirclement and, unable to dose properly with mittens on, swallows the patrol's full bottle of Pervitin—30 tablets (90 mg) of methamphetamine. After a brief surge, he develops psychosis, is disarmed by teammates, and skis on “autopilot,” later waking alone after covering about 100 km. He mistakenly skis through a Soviet camp, burns down a cabin by lighting a fire on the floor, survives on pine buds, steps on a landmine, and spends a week in a ditch before rescue in early April—two and a half weeks later—with a 200 bpm resting heart rate, 43 kg body weight, and frostbite requiring toe amputations. The episode adds WWII stimulant history and argues war repeatedly pushes armies toward chemical solutions. 00:00 Podcast Intro 00:28 Lapland Night Chase 02:28 Pervitin Decision 03:21 Finland Versus USSR 07:07 Aimo Early Life 11:43 Elite Ski Scouts 15:43 Ambush And Escape 21:00 What Is Pervitin 26:14 Pervitin Kicks In 27:24 Psychosis Takes Hold 30:17 Disarmed and Blackout Skiing 31:43 Autopilot Navigation West 34:48 Soviet Camp Close Call 36:16 Cabin Fire Hallucinations 37:10 Crash Hunger and Landmine 38:51 Week in the Ditch 40:31 Rescue and Aftermath 43:02 Life After the War 44:02 Story Published and Legacy 45:26 War and Drugs Through History 48:40 Limits of Human Will 50:29 Closing and Listener Support Listen AD FREE: Support our podcast at patreaon: http://patreon.com/TheCruxTrueSurvivalPodcast Email us! thecruxsurvival@gmail.com Instagram https://www.instagram.com/thecruxpodcast/ Get schooled by Julie in outdoor wilderness medicine! https://www.headwatersfieldmedicine.com/ REFERENCES Koivunen, Aimo — Personal memoir account published in Kansa Taisteli (1978). Wikipedia — "Aimo Koivunen." Grokipedia — "Aimo Koivunen." Commonplace Fun Facts — English translation of Koivunen's memoir excerpts. Ohler, Norman — Blitzed: Drugs in the Third Reich (2016). Wikipedia — "Otto Friedrich Ranke." Wikipedia — "Pervitin" and "Drug Policy of Nazi Germany." Yle (Finnish Broadcasting Company). MyHeritage / Geni — Genealogical records. Wikipedia — "Long-range reconnaissance patrol" and "Detached Battalion 4." Finnish Army Jaeger Brigade / Bushcraft USA — rakovalkea and kaukopartio equipment. PMC / Brieflands — stimulant psychosis research. PNAS / Nature Neuroscience — spatial navigation neuroscience. History.com / VA History — Vietnam and Civil War drug history. Wikipedia — "Winter War." WFYI / HyperWar — Finnish mobilization 1939. History of Finland — Wikipedia. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In this episode, Dr Elle Wadsworth talks to Dr Damon Morris, a Research Fellow in the Sheffield Addictions Research Group, School of Medicine and Population Health, at the University of Sheffield, UK. The interview covers Damon's research article modelling the economic effects of reducing the consumption of unhealthy commodities.The drive to conduct this study [01:30]The economic outputs of interest to capture the net effects of the economy [03:00]What a simulation model is [04:10] An explanation of the commercial determinants of health input-output model [05:06]The unhealthy commodities used in this study [06:20]The key findings of the study [07:28]The difference between the off-trade and on-trade alcohol results [08:50]A summary of the key results [10:22]The break-even reallocation rate: the point at which the negative economic impacts of reduced spending are exactly offset by the positive impacts of increased spending on other products [10:55]The implications of the findings for policy makers [13:10]The generalisability of the findings to outside the UK [14:44]The missing pieces of the model [15:50]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle holds voluntary roles at The Loop, a non-profit service provider of drug checking in the UK, and the International Society for the Study of Drug Policy. About Damon Morris: Damon is a Research Fellow in the Sheffield Addictions Research Group (SARG), School of Medicine and Population Health, at the University of Sheffield. Damon's current research is in the area of public health and labour economic modelling, primarily in ongoing development of the Sheffield Tobacco and Alcohol Policy Model (STAPM), an economic and epidemiological model of alcohol and tobacco consumption and health dynamics used to appraise public health policy.Declarations of interest: None Original article: Modelling the economic effects of reducing the consumption of unhealthy commodities: An inter-sectoral input–output approach https://doi.org/10.1111/add.70336The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music by Jack Shakespeare Hosted on Acast. See acast.com/privacy for more information.

Walmart's Do-Over Drug Policy.Something I never knew before but Walmart has a 2nd chance drug policy. Before you judge this program, you should know you might want to implement it into your won company. Wait till you hear the details and then let us know if you agree with the panel. TalkCDL Trucking Podcast. Walmart's Do-Over Drug Policy NCI Trucking – One of the best carriers looking for drivers for company drivers and lease drivers Truck Parking Club – When you need a parking space for that Big Rig, Truck Parking Club has you resting in seconds Carter Lumber Local Trucking Jobs – Employing Truckers that want to be home every Day Summar Financial Your Cash Flow Starts Here http://Truckinginsuranceguy.com For an insurance agent with old fashion values, call 507-884-1312 Top Ten Most Dangerous Trucking Companies Wide Open Road Compliance LLC Interviews are heating up on TalkCDL Want to get hot and heavy with a TalkCDL interview? Want to show the world your successes and failures? We are looking to get raw and tell your story on the show. Our audience loves a good and honest interview. Write to Ruthann@TalkCDL.com or Troy@TalKCDL.com and tell us about you. We prefer to a video though zoom or if youre shy we can do a phone interview. We are looking forward to hearing from you

In this episode, newly confirmed U.S. Drug Czar Sara Carter joins Lisa to discuss America’s escalating fight against fentanyl, cartel violence, and the global drug trade. Carter shares behind-the-scenes insight into her confirmation process and her current role leading the Office of National Drug Control Policy under President Trump. She details a coordinated “whole-of-government” strategy aimed at cutting off drug supply chains, dismantling cartel networks, and saving American lives. The conversation dives deep into the takedown of cartel leader El Mencho, revealing how U.S. and Mexican forces collaborated on one of the most significant operations against organized crime in recent years—and what it signals moving forward.See omnystudio.com/listener for privacy information.

In this engaging episode of John Solomon Reports, we dive into the latest developments in American politics and policy, with a special focus on the War on Drugs. John Solomon welcomes Sara Carter, the White House Drug Czar, who discusses the significant updates to the national drug strategy, emphasizing the urgent need to address the opioid crisis and the evolving tactics of drug cartels. Carter's insights shed light on how the administration is modernizing its approach to combatting drug-related issues in today's landscape.Listeners will also hear about the latest economic news, as job creation exceeded expectations, with 115,000 new jobs reported in April. Solomon highlights the implications of this data amidst ongoing global tensions, including the Iran war and rising gas prices.In a groundbreaking ruling, the Virginia Supreme Court declared the recent redistricting unconstitutional, a decision that could reshape the political landscape in favor of Republicans. Attorney General Alan Wilson of South Carolina joins the show to discuss the ramifications of this ruling and the ongoing redistricting efforts in his state, particularly concerning Congressman Jim Clyburn's seat.To round out the episode, Cliff Maloney shares his perspectives on the current political climate and the initiatives he's championing. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr Elle Wadsworth talks to Dr Amy Peacock, an Associate Professor and Deputy Director of the National Drug and Alcohol Research Centre, University of New South Wales, and Dr Monica Barratt, an Associate Professor at Australia's National Drug Research Institute, Curtin University. The interview covers Amy and Monica's research article examining the availability of nitazenes via cryptomarkets and surface web shops.What are nitazenes? [01:30]What are cryptomarkets? [03:00]Why did Monica and Amy look for nitazenes on cryptomarkets? [04:40] Why nitazenes are popular now [06:12]The key findings of the study [07:41]The change of the main country of origin for nitazenes [10:55]The turnover of cryptomarkets [12:11]The implications of the findings for policymakers in Australia [14:20]The next steps in this research area [17:20]About Elle Wadsworth: Elle is an academic fellow with the Society for the Study of Addiction. She is based at the University of Bath with the Addiction and Mental Health Group and her research interests include drug policy, cannabis legalisation, and public health. Elle holds a voluntary role at The Loop, a non-profit service provider of drug checking in the UK. About Amy Peacock: Amy is an Associate Professor, National Health and Medical Research Council (NHMRC) Emerging Leadership Fellow and Deputy Director of the National Drug and Alcohol Research Centre, University of New South Wales. She is also Program Lead for Drug Trends, a national monitoring system identifying trends in illicit drug use, markets and harms that is funded by the Australian Government Department of Health, Disability and Ageing.About Monica Barratt: Monica is an NHMRC Emerging Leadership fellow at Australia's National Drug Research Institute (Curtin University), recognised internationally for generating policy and practice relevant insights into the reduction of health harms for people who use unregulated drugs. Monica has published 158 peer-reviewed articles with over 10K Google Scholar citations. Monica's research has been supported domestic and international competitive health-related funds. Her key partners include organisations that represent people with lived-living experience of drug use and peak bodies. She holds editor roles at the International Journal of Drug Policy and Drug and Alcohol Review.Declarations of interest: Monica holds four voluntary roles for community organisations engaged in harm reduction service provision and advocacy. She is the National Research Lead for The Loop Australia, a non-profit service provider of drug checking in Australia. She serves on the boards of directors of three harm reduction charities: Bluelight Communities Ltd (Chair), Students for Sensible Drug Policy Australia (Treasurer), and the Australian Psychedelic Society (Member). Amy has no interests to declare. Original article: Availability of nitazenes via cryptomarkets and surface web shops: An observational study https://doi.org/10.1111/add.70350 The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.Music by Jack Shakespeare. Hosted on Acast. See acast.com/privacy for more information.

Last month we saw a big shift in the federal government's approach to psychedelic medicine.Specifically, following an executive order by President Trump, the FDA announced it is fast-tracking its review of several clinical trials of psychedelic drugs for patients with mental health disorders. The executive order also directed more funds towards psychedelic research and a review of psychedelics' status as highly restricted Schedule 1 substances. To help us understand what all this means for the future of psychedelic medicine and the neuroscience of psychedelics, we're joined by Boris Heifets, an anesthesiologist at Stanford Medicine who runs a lab studying how psychedelics affect the nervous system and their impact on patients with psychiatric conditions.Learn MoreThe Heifets Lab at Stanford MedicineFDA plans ultra-fast review of three psychedelic drugs following Trump directive (Associated Press, 2026)Trump's order on psychedelics could have far-reaching science consequences (Scientific American, 2026)Psychedelics, placebo, and anesthetic dreams (From Our Neurons to Yours, 2024)Pychedelics inside out — how do LSD and psilocybin alter perception? (From Our Neurons to Yours, 2024)The power of psychedelics meets the power of placebo (From Our Neurons to Yours, 2024)Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Nature, 2024)Magnesium–ibogaine therapy effects on cortical oscillations and neural complexity in veterans with traumatic brain injury (Nature Mental Health, 2025)Send us a text!Thanks for listening! If you're enjoying our show, please take a moment to give us a review on your podcast app of choice and share this episode with your friends. That's how we grow as a show and bring the stories of the frontiers of neuroscience to a wider audience.We want to hear from your neurons! Email us at at neuronspodcast@stanford.eduLearn more about the Wu Tsai Neurosciences Institute at Stanford and follow us on Twitter, Facebook, and LinkedIn. 

Dr. Brick Lantz of Christian Medical and Dental Association talks about the politics and monies behind both the fast-tracking of reviews of certain psychedelic drugs and moving marijuana to a schedule 3 drug, and the lack of any medical evidence supporting any such moves.  He also addresses some potential treatments for pancreatic cancer with the help of mRNA vaccines. Theologian Michael Kruger, co-author of "The Good News Family Devotional," talks about leading your family, young and old, toward God through meaningful time together in the Word.   The Reconnect with Carmen and all Faith Radio are made possible by your support. Give now: Click here

The government is cracking down on nitrous oxide after police linked its use to serious and fatal crashes. Sam Lasham, national coordinator for Students for Sensible Drug Policy Aotearoa spoke to John Campbell.

The Justice Department has moved medical marijuana to Schedule III, unlocking major tax benefits for licensed businesses. But the change leaves out recreational markets, where many Black-owned cannabis companies operate, raising concerns about equity in the industry. Subscribe to our newsletter to stay informed with the latest news from a leading Black-owned & controlled media company: https://aurn.com/newsletter Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

This week, Coach Blu speaks to Richard Baum, a former acting drug czar and Georgetown professor, draws on decades of experience in drug policy to offer a thoughtful look at the opioid crisis and broader addiction challenges. In this episode, he discusses how addiction is not just a personal issue, but a public health problem that affects families, communities, and government systems. He explains that effective responses require more than punishment or short-term fixes. Instead, they need a balanced approach that includes prevention, treatment, recovery support, and smart policy. Baum highlights the importance of evidence-based strategies, such as expanding access to treatment, supporting harm reduction efforts, and making sure people struggling with addiction can get help without unnecessary barriers. He also emphasizes that lasting progress depends on cooperation between communities, healthcare providers, and government leaders. By working together, they can create systems that reduce overdose deaths, improve recovery outcomes, and address the root causes of substance use disorders. Chapters 00:00 Introduction to the Podcast and Guest 01:58 Richard Baum's Background and Experience 04:45 The Impact of the Opioid Crisis 09:30 Lessons from Personal Stories 12:00 The Role of Policy in Addressing the Crisis 16:04 Medication-Assisted Treatment in Prisons 20:41 Shifts in Law Enforcement's Approach 26:45 Regulation of Treatment Centers 29:07 The Need for Regulation and Expert Oversight 30:07 Underinvestment in the Opioid Crisis Response 34:18 The Importance of Prevention and Education 39:37 Innovations in Drug Policy and Treatment 46:37 Richard Baum's Book and Resources for Change Guest links LinkedIn - https://linkedin.com/in/richardjbaum Twitter - https://twitter.com/richardjbaum Resources Inside America's Opiate Crisis (Book) - https://www.amazon.com/dp/B0CXYZ1234 Richard Baum's Website - https://richardjbaum.com Office of National Drug Control Policy - https://odcp.gov Join Coach Blu and Team Addict II Athlete and begin your recovery with a tram behind you! Our online addiction and mental health program provides live group sessions with Coach Blu, our weekly Home Base, recovery meeting, therapeutic assignments, and educational information at a fraction of what a therapeutic treatment program would require. Take You Mark, Get Set, Let's Go, and click the link below https://www.skool.com/addict-ii-athlete-5988/about?ref=9090e81114674311874340c02b1095d0 Please join Addict to Athlete's Patreon support page and help us turn the mess of addiction into the message of sobriety! https://www.patreon.com/addicttoathlete Please visit our website for more information on Team Addict to Athlete and Addiction Recovery Podcasts. https://www.AddictToAthlete.org   It's time! Skool is in session! Welcome to Addict II Athletes new on line mental health and addiction program! You will find:   https://www.skool.com/addict-ii-athlete-5988/about?ref=9090e81114674311874340c02b1095d0

Send us Fan MailToday's conversation is part of a new series we're launching — ‘Past Forward: Lessons for the Next Century.' In this series, we examine pivotal moments, systems, and individuals from the past - not to relive them, but to better understand how they continue to shape the world we are building.  Because many of the defining forces of our time - globalized networks, technological escalation, public health crises, and the evolution of law enforcement - did not emerge in isolation. They evolved from earlier systems, earlier decisions, and earlier actors operating under very different constraints.Today's episode is titled: ‘The Architecture of a Drug Empire — and the Systems It Forced the World to Build.'Carlos Lehder is one of the central figures in the rise of the Medellín Cartel, and someone who played a key role in developing the logistics and infrastructure that helped transform the global cocaine trade. After decades of imprisonment, he has recently published a firsthand account of that era in his book, Life and Death of the Medellín Cartel ( https://www.amazon.com/DEATH-MEDELL%C3%8DN-CARTEL-CARLOS-LEHDER/dp/B0FDL8D66M/ ) a narrative that traces his journey from early criminal activity to the creation and evolution of one of the most consequential criminal networks in modern history.This conversation is not about glamorizing crime or revisiting mythology. It is about understanding systems - how they scale, how they collide with institutions, and how their consequences ripple across decades.Across this discussion, we explore themes that connect directly to many conversations we've had on this show - from the evolution of global law enforcement and emerging technologies, to drug policy, harm reduction, incarceration, and even healthcare behind bars.And ultimately, the goal is simple: to extract lessons. Lessons about innovation and unintended consequences. Lessons about policy and adaptation. And lessons that may help us better understand - and perhaps better navigate - the systems we are building for the future.#PastForward #ProgressPotentialPossibilities #CarlosLehder #MedellinCartel #PabloEscobar #DrugPolicy #WarOnDrugs #TrueCrime #Geopolitics #CriminalJustice #LawEnforcement #DEA #HistoryMatters #SystemsThinking #GlobalSecurity #OrganizedCrime #Innovation #PublicHealth #HarmReduction #FutureOfPolicing #AIandCrime #DrugEpidemic #ColdWarHistory #TransnationalCrime #PodcastSupport the show

Dr. Katharine Neill Harris is an expert in drug policy and treatment. She dropped by the Saving America studio to chat about the addiction crisis in America, how we can do better dealing with substance abuse issues, and the drug policy bills being discussed in Texas' legislature. Thanks for joining me for this episode! I'm a Houston- based attorney, run an HR Consulting company called Claremont Management Group, and am a tenured professor at the University of St. Thomas. I've also written several non-fiction political commentary books: Bad Deal for America (2022) explores the Vegas-style corruption running rampant in Washington DC, while The Decline of America: 100 Years of Leadership Failures (2018) analyzes – and grades – the leadership qualities of the past 100 years of U.S. presidents. You can find my books on Amazon, and me on social media (Twitter @DSchein1, LinkedIn @DavidSchein, and Facebook, Instagram, & YouTube @AuthorDavidSchein). I'd love to hear from you! As always, the opinions expressed in this podcast are mine and my guests' and not the opinions of my university, my company, or the businesses with which I am connected.

En este episodio hablamos con Arturo Álvarez-Roldán sobre un estudio pionero de la Universidad de Granada que analiza la evolución jurídica y social de los clubes sociales de cannabis en España.A partir de más de 30 años de transformaciones legales, el trabajo —publicado en International Journal of Drug Policy— explora cómo estos espacios surgieron en un contexto de ambigüedad normativa, prosperaron en “zonas de tolerancia” y terminaron enfrentándose a restricciones judiciales que frenaron su expansión.Durante la conversación, abordamos no solo el caso de los clubes de cannabis, sino también qué nos dice este fenómeno sobre cómo cambian las políticas públicas, el papel de la gobernanza multinivel y cómo la innovación social puede abrir camino incluso en contextos legales inciertos.Una charla para entender mejor la relación entre derecho, sociedad e innovación desde una mirada crítica y actual.---------------------------Radiolab, la radio universitaria de la Universidad de Granada, es un espacio de participación de la comunidad universitaria abierto a la ciudadanía. Nuestra universidad, como institución de aprendizaje está abierta al conocimiento y al debate. Desde su autonomía proporciona espacio para un debate libre y crítico, abierto a la pluralidad de voces y a la demandas de la sociedad dentro del marco de los derechos humanos y de los valores de nuestra institución. De este modo, constatamos que las opiniones vertidas en nuestros programas son exclusiva responsabilidad de quienes las emiten, sin representar un posicionamiento de la institución como tal. Defendemos la libertad de expresión y la comunicación en el espacio público como una forma de hacer ciudadanía y avanzar en el conocimiento. 

Emily Dufton joins me to talk about how the death of her high school friend after 15 years of escalating opioid use led her on a journey to uncover the origins of the American opioid crisis and our failure to treat patients. She traces those roots back to the well‑intentioned but misguided efforts of the Nixon Administration in the 1970s, the punitive turn of the Reagan‑era War on Drugs, and the policies that followed. Emily also connects these policy choices to the rise of pharmaceutical profiteering—from Purdue Pharma, the maker of OxyContin, to other drug manufacturers who have collectively paid more than $60 billion in fines and civil penalties for practices that, in many ways, helped start the fire and then attempted to sell the hose.To read Emily's book, Addiction, Inc.:Addiction, Inc.: Medication-Assisted Treatment and America's Forgotten War on Drugs, DuftonContact me at silverliningshandbookpod@gmail.comCheck out the Silver Linings Handbook website at:https://silverliningshandbook.com/Check out our Patreon to support the show at:https://www.patreon.com/thesilverliningshandbookJoin our Facebook Group at:https://www.facebook.com/groups/1361159947820623Visit the Silver Linings Handbook store to support the podcast at:https://www.bonfire.com/store/the-silver-linings-handbook-podcast-storeVisit The True Crime Times Substack at:https://truecrimemessenger.substack.comThe Silver Linings Handbook podcast is a part of the ART19 network. ART19 is a subsidiary of Wondery and Amazon Music.See the Privacy Policy at https://art19.com/privacy and the California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, newly confirmed U.S. Drug Czar Sara Carter joins Lisa to discuss America’s escalating fight against fentanyl, cartel violence, and the global drug trade. Carter shares behind-the-scenes insight into her confirmation process and her current role leading the Office of National Drug Control Policy under President Trump. She details a coordinated “whole-of-government” strategy aimed at cutting off drug supply chains, dismantling cartel networks, and saving American lives. The conversation dives deep into the takedown of cartel leader El Mencho, revealing how U.S. and Mexican forces collaborated on one of the most significant operations against organized crime in recent years—and what it signals moving forward. Carter also breaks down: How fentanyl is entering the U.S. through borders, ports, and mail systems The role of China in supplying precursor chemicals Why cartel networks are becoming more sophisticated and dangerous The connection between drug trafficking, national security, and terrorism The reported drop in fentanyl flow and overdose deaths How the administration is targeting both supply AND demand She also delivers a passionate message about unity, urging Americans to come together across political lines to combat addiction and protect future generations.See omnystudio.com/listener for privacy information.

AFL CEO Andrew Dillon joined Tom Elliott for a wide-ranging interview on 3AW Mornings.See omnystudio.com/listener for privacy information.

When President Trump signed an executive order classifying fentanyl as a weapon of mass destruction, some who have lost loved ones to the powerful synthetic opioid applauded the decision. But a drug historian argues The White House is making serious mistakes in its approach to the crisis.In this episode of Grieving Out Loud, historian Dr. David Herzberg looks back at earlier substance crises in the United States and discusses what went wrong, what went right, and what lessons those experiences might hold today. He explores how history can inform today's policies, the unintended consequences of past approaches, and why understanding the bigger picture is crucial for tackling the opioid epidemic. By examining decades of drug trends and responses, Herzberg offers a perspective that goes beyond politics, helping listeners think critically about how America can respond more effectively to fentanyl and other substance crises.Explore David's website and books here. Dr. Herzberg says research shows that roughly 75% of people who use even the most addictive drugs like heroin and cocaine do not develop an addiction. This means addiction risk is shaped less by the drug itself and more by a person's circumstances, environment, and biology. That is why prevention, early intervention, and access to treatment matter so much. 1. National Institute on Drug Abuse (NIDA) / Addiction Center (sourced from national survey data): “Approximately 25% of people who use illicit drugs develop an addiction.” — AddictionCenter.com, sourced from national substance use data2. Peer-reviewed academic literature: Schlag, A.K. (2020). “Percentages of problem drug use and their implications for policy making: A review of the literature.” International Journal of Drug Policy. Key finding: “The majority of drug use is episodic, transient and generally non-problematic.”If you enjoyed this episode, check out the following: How Do We End the Fentanyl Epidemic? A Candid Conversation with a Former DEA ChiefCan We Save Lives While Cutting Funding? A Tough Conversation at the TopHe Send a textBehind every number is a story of a life cut short, a family shattered, and a community devastated.They were...daughterssonsmothersfathersfriendswiveshusbandscousinsboyfriendsgirlfriends.They were More Than Just A Number. Support the showConnect with Angela Follow Grieving Out Loud Follow Emily's Hope Read Angela's Blog Subscribe to Grieving Out Loud/Emily's Hope Updates Suggest a Guest For more episodes and information, just go to our website, emilyshope.charityWishing you faith, hope and courage!Podcast producers:Casey Wonnenberg King & Kayli Fitz

Billy kicks off a shambolic show with the All Sports Report, as an NBA record is almost broken. Channel 7 Chief Footy Reporter Mitch Cleary is in studio for the first of his weekly appearances with the latest footy news - including potential changes to the AFL's Drug Policy, and Hawthorn's Scissor Lift drama. Zane and Mitch battle it out in the Hump Day Quiz, and we want you to help Billy with his jokes. Mick Molloy calls in to preview tonight's episode of Front Bar, then it's the Wacky World of William - with a HR warning for JB. Billy goes one-on-one with Hawthorn champion Jack Gunston, then finishes the show with a joke about a precariously placed golf ball.See omnystudio.com/listener for privacy information.

See omnystudio.com/listener for privacy information.

The sports reporter has discussed the policy with Ross and Russ, after the news it's getting an overhaul.See omnystudio.com/listener for privacy information.

Chief AFL writer for The Age, Jake Niall joined 3AW Breakfast to discuss the changes.See omnystudio.com/listener for privacy information.

GPPR Senior Editor Brennan Gallagher (MPP '27) sits down with drug policy advisor, author, and former Director of the Office of National Drug Control Policy, Richard Baum. In Episode two, Baum shares his thoughts on some of todays most pressing issues in drug policy, from enforcement and incarceration to marijuana, and reflects on the direction we can take to limit harm in our communities. Learn more about Richard and his book, "Inside America's Opioid Crisis," at richardjbaum.com

This episode is a conversation with John Walsh, WOLA's director for Drug Policy and the Andes, about the ongoing U.S. military attacks on civilian boats in the Caribbean and Pacific Oceans. When Walsh and host Adam Isacson recorded this episode, on February 13, 2026, 35 attacks had killed at least 131 people since September 2, 2025—an average of four killings every five days—and another attack later that day killed 3 more people. Walsh and Isacson just published a WOLA commentary, "The Boat Strikes are Still Happening: Five Things You Need to Know," warning against the dangerous normalization of extrajudicial executions carried out directly by the U.S. military. Five months into this campaign, the strikes are fading from public attention despite their illegality. Media coverage has dwindled from the intense scrutiny of September and the revelations about "double tap" strikes on survivors in December to a trickle of stories. This normalization poses dangers: the justifications being used could extend to other victims in other contexts, and elements of the U.S. military appear to be accepting unlawful orders. There is no congressional authorization for military force against drug traffickers. Under international law, the United States is not engaged in an armed conflict with drug cartels—designating groups as foreign terrorist organizations does not confer wartime authorities. From a drug policy perspective, Walsh argues these strikes are futile. After five months, there is no evidence of a disruption to cocaine supplies. Drug trafficking organizations are highly adaptive, with alternative routes readily available. The administration's own recognition that traditional interdiction didn't work led them to this extreme escalation, but killing traffickers at sea will not fundamentally alter market dynamics driven by constant demand and enormous profits under prohibition. The boat strikes, if "normalized," could prepare the ground for grave future outcomes. The administration's willingness to label anonymous victims as "narcoterrorists" creates a template for applying similar labels to domestic opponents—something already visible in the characterization of ICE critics and the victims of Chicago and Minneapolis shootings as "domestic terrorists." Walsh notes that President Trump has expressed his desire to deploy military forces against "the enemy within" on U.S. streets, and the compliance of Southern Command with these illegal orders suggests obedience to the president over the Constitution. "The illegality is not a bug, it's a feature," Walsh concludes. Walsh concludes by emphasizing the importance of litigation on behalf of victims' families, the moral voice of faith leaders, and continued media attention to prevent normalization. These strikes, he argues, are not a peripheral story but central to the administration's declared strategy of dominating the Western Hemisphere through coercion.

GPPR Senior Editor Brennan Gallagher (MPP '27) sits down with drug policy advisor, author, and former Director of the Office of National Drug Control Policy, Richard Baum. In Episode One, Baum reflects on his career in Washington and shares what he's learned over decades of change in U.S. drug policy and the evolving War on Drugs. Join us next week for Episode Two. To learn more about Richard and his upcoming book: https://richardjbaum.com/

John Maytham speaks to Executive Director of the UN’s International Drug Policy Consortium, Anne Fordham on the latest report – showcasing the fight against drug crimes is failing. Afternoon Drive with John Maytham is the late afternoon show on CapeTalk. Presenter John Maytham is an actor and author-turned-talk radio veteran and seasoned journalist. His show serves a round-up of local and international news coupled with the latest in business, sport, traffic and weather. The host’s eclectic interests mean the program often surprises the audience with intriguing book reviews and inspiring interviews profiling artists. A daily highlight is Rapid Fire, just after 5:30pm. CapeTalk fans call in, to stump the presenter with their general knowledge questions. Another firm favourite is the humorous Thursday crossing with award-winning journalist Rebecca Davis, called “Plan B”. Thank you for listening to a podcast from Afternoon Drive with John Maytham Listen live on Primedia+ weekdays from 15:00 and 18:00 (SA Time) to Afternoon Drive with John Maytham broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show go to https://buff.ly/BSFy4Cn or find all the catch-up podcasts here https://buff.ly/n8nWt4x Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

Over the weekend, news broke that Sixers' Forward Paul George is suspended for 25 games for violating the NBA's anti-drug policy for taking a drug that he says was for his mental health. What do you make of it? Will the Sixers trade VJ Edgecombe at the deadline for a superstar like Giannis Antetokounmpo?

Paul George is hit with a 25-game suspension after violating the NBA's Anti-Drug Policy. The WIP Midday Show breaks down the impact of the suspension, the league's stance, and what this means for George and his team moving forward.

Shannon Sharpe and Chad “Ochocinco” Johnson react to the NFL is planning to have a major salary cap increase, Justin Jefferson wonders what would of happened if the Minnesota Vikings kept Sam Darnold, and Paul George is suspended 25 games for violating the NBA anti drug policy and much more! Subscribe to Nightcap presented by PrizePicks so you don’t miss out on any new drops! Download the PrizePicks app today and use code SHANNON to get $50 in lineups after you play your first $5 lineup! Visit https://prizepicks.onelink.me/LME0/NI... 0:00 - NFL informs clubs of projected salary cap18:51 - Justin Jefferson wonders what wouldve happened if thy kept Sam Darnold26:04 - 2026 Senior Bowl exposes Diego Pavia as a Short King29:35 - Paul George violated NBA anti-drug policy37:01 - Jason Kidd on Cooper Flagg criticism42:26 - Demond Wilson aka Lamont Sanford passes away47:01 - Q & Aaayyy (Timestamps may vary based on advertisements.) #ClubSee omnystudio.com/listener for privacy information.

AP correspondent Julie Walker reports the NBA suspends Philadelphia 76ers' Paul George 25 games for violating anti-drug policy.

This special episode of AJP Audio brings together the editors of the American Journal Psychiatry and the AJP Residents' Journal to discuss important and impactful articles published in 2025. 00:39   Ned H. Kalin, M.D., discusses "Transcriptomic Analysis of the Human Habenula in Schizophrenia" by Ege A. Yalcinbas, Ph.D., et al. 06:23   Elisabeth Binder, M.D., Ph.D., discusses "Copy Number Variant Architecture of Child Psychopathology and Cognitive Development in the ABCD Study" by Zhiqiang Sha, Ph.D., et al. 11:17   Kathleen T. Brady, M.D., Ph.D., discusses "High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies" by Stephanie Lake, Ph.D., et al. 15:35   David A. Lewis, M.D., discusses "20 Years of Aberrant Salience in Psychosis: What Have We Learned?" by Philip R. Corlett, Ph.D., and Kurt M. Fraser, Ph.D. 17:27   William M. McDonald, M.D., discusses "Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research" by Roger S. McIntyre, M.D., F.R.C.P.C., et al. 24:04   Daniel S. Pine, M.D., discusses "Cognitive Behavioral Therapy and Lisdexamfetamine, Alone and Combined, for Binge-Eating Disorder With Obesity: A Randomized Controlled Trial" by Carlos M. Grilo, Ph.D., et al. 26:06   Carolyn Rodriguez, M.D., Ph.D., discusses "Randomized Controlled Trial of the Effects of High-Dose Ondansetron on Clinical Symptoms and Brain Connectivity in Obsessive-Compulsive and Tic Disorders" by Emily R. Stern, Ph.D., et al. 30:26   Sean T. Lynch, M.D., discusses "From Medical Practice to Mass Incarceration: A Historical Analysis of Racial and Ethnic Targeting in U.S. Drug Policy" by Rathisha Pathmathasan, D.O., et al. Transcript Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Podcasts, Spotify, or wherever you listen to it. Subscribe to the podcast here. Listen to other podcasts produced by the American Psychiatric Association. Browse articles online. How authors may submit their work. Follow the journals of APA Publishing on Twitter. E-mail us at ajp@psych.org  

What if cannabis education focused on benefits, not fear?Daniel Bear, PhD returns to break down the cannabis industry THC obsession, Canada's cannabis tax imbalance, and why mindful consumption—not prohibition—is the future of cannabis policy. Daniel tackles falling prices, rising taxes, disappearing profit margins, and the ongoing threat of the illicit market. He explores how high-THC marketing pressures, youth protection, and consumer education can seem to be in conflict. Everyone, except governments, hat taxes, but Daniel believes smarter tax policies could stabilize the market without compromising safety. Daniel also unveils an exciting new 'project: HERBy, the Helpful Education for Responsible Benefit-maximization tool. AI can be your therapist, or your research assistant, so why not a mindful cannabis consumption chatbot. This tool is built on groundbreaking research from his recent peer-reviewed study, "Harm reduction isn't enough: Introducing the concept of Mindful Consumption and Benefit Maximization (MCBM)," published in the International Journal of Drug Policy. Listen now to learn whether Canada is still on the right path—and what industry, government, and consumers must do next to ensure legalization succeeds for everyone.HERBy Chatbot - websiteDaniel Bear PhD - LinkedIn-responsum.caTranscripts, papers and so much more at: reefermed.ca

Today’s Phone Tap victim is a hiring manager who has been trying to fill a spot for WEEKS! So, we’re sending our least reliable candidate JOSE out hunting for some obscure job perks.See omnystudio.com/listener for privacy information.

FULL SHOW: Thursday, November 27th, 2025 Curious if we look as bad as we sound? Follow us @BrookeandJeffrey: Youtube Instagram TikTok BrookeandJeffrey.com See omnystudio.com/listener for privacy information.

Today’s Phone Tap victim is a hiring manager who has been trying to fill a spot for WEEKS! So, we’re sending our least reliable candidate JOSE out hunting for some obscure job perks.See omnystudio.com/listener for privacy information.

Episode 206: Street Medicine and Harm Reduction.  Mohammed Wase (medical student) and Dr. Singh describe what it is like to provide health care on the streets. They share their personal experiences working in a street medicine team. They describe the practice of harm reduction and emphasize the importance of respecting autonomy and being adaptable in street medicine. Written by Mohamed Wase, MSIV, American University of the Caribbean. Editing by Hector Arreaza, MD. Hosted by Harnek Singh, MD.You are listening to Rio Bravo qWeek Podcast, your weekly dose of knowledge brought to you by the Rio Bravo Family Medicine Residency Program from Bakersfield, California, a UCLA-affiliated program sponsored by Clinica Sierra Vista, Let Us Be Your Healthcare Home. This podcast was created for educational purposes only. Visit your primary care provider for additional medical advice.Introduction Dr. Singh: Welcome to another episode of our podcast, my name is Dr. Harnek Singh, faculty in the Rio Bravo Family Medicine Residency Program. Today we have prepared a great episode about street medicine, a field that has grown a lot during the last decade and continues to grow now. We are joined by a guest who is passionate about this topic. Wase, please introduce yourself.Wase: Hello everyone, my name is Mohammed, many know me as Wasé, I am a 4th year medical student from the American University of the Caribbean. Today we're diving into a topic that sits at the intersection of medicine, compassion, and public health — Street Medicine and Harm Reduction. We're going to step outside with this episode, literally, away from the clinic and hospital, to explore more about what care looks like in the streets. Historic background: How did street medicine start?Wase: The roots of Street Medicine in the United States go back to Dr. Jim Withers in Pittsburgh in the 1990s, who literally began by dressing as a homeless person and providing care on the streets to build trust. His efforts have shaped street medicine to what it is today. It combines primary care, mental health, and social support. Dr. Singh: For family physicians, this model aligns perfectly with our holistic approach. We don't just treat diseases; we treat people in context — their environment, their challenges, their stories. What is the main population seen by a street medicine team?Wase: This patient population includes those struggling with homelessness, housing insecurity, food insecurity, substance use disorders; with patients being preoccupied on where they will sleep that night or when their next meal comes, they do not have the luxury of prioritizing their health. Street Medicine is a powerful outreach program to bring care to them in order to provide equitable care within our community. Dr. Singh: How is street medicine different than caring for patients in the clinic?Wase: Working on the street means we have to think differently about what healthcare looks like — and that's whereharm reductioncomes in.What is Harm Reduction?Wase: Harm reduction is a public health philosophy that focuses on reducing the negative consequences of high-risk behaviors, rather than demanding complete abstinence.Dr. Singh: Preventive care is the backbone of family medicine. For example, we keep up with the USPSTF guidelines and make sure our patients are up to date with their screenings. But what does that look like in the street medicine setting? Wase: In practice, that might mean:-needle exchange program: Offering clean syringes to prevent HIV transmission and removing used needles-distributing naloxone to prevent overdose deaths-offering fentanyl test-strips to prevent use of substances that are unknowingly laced with fentanylDr. Singh: Also:-providing condoms to prevent sexually transmitted infections-providing wound care to prevent further spread of infectionWase: Yes, the idea is: people are going to engage in risky behaviors whether or not we approve of it, so let's meet them with compassion, tools, and trust instead of judgment. Harm reduction also applies beyond substance use; think about safer sex education, or even diabetic foot care among people who can't refrigerate insulin or change shoes daily. It's all about meeting people where they areandkeeping them alive and engaged in care. Planning in Street Medicine: Wase: It takes careful disposition planning and aftercare for this population. Instead of the traditional outpatient setting where we can place referrals and expect our patients to follow through with them. On street medicine, for follow up visits it requires arranging transportation, finding a pharmacy close in proximity, educating and counseling on medication adherence and how to make it, and making sure they have some sort of shelter to get by. Dr. Singh: Let's describe a typical street med encounter.Wase: A typical Street Medicine encounter might look like this: a small team — usually a physician, nurse, social worker, and sometimes a peer advocate — goes out with backpacks of supplies. They might start with wound care, blood pressure checks, or even medication refills. But what's just as important is the relationship-building. Sometimes, the first visit isn't about medicine at all — it's about showing up consistently.Over time, that trust opens the door for conversations about addiction treatment, mental health, and preventive care. For example, in some California Street Medicine programs, teams are treating chronic conditions like hypertension, diabetes, and hepatitis C, right where patients live with the same evidence-based care we'd give in a clinic. One of my favorite quotes from Street Medicine teams is: “We're not bringing people to healthcare; we're bringing healthcare to people.”Challenges in Street Medicine:Wase: The populations that you will encounter include many people who will often downplay their own health concerns and prior diagnoses. Unfortunately, this is usually from countless months or years of feeling neglected by our healthcare system. Some may even express distrust in our healthcare system and healthcare providers. Patient will, at times, be apprehensive to receive care or trust you enough to tell their story. Dr. Singh: Interviewing patients is a critical aspect of providing equitable care on the streets. It is always important to offer support and medical care, even if the patient denies it, always reassure that your street medicine clinic will be around every week and ready for them when they would like to seek care. Wase: Respecting patient autonomy is an utmost concern as well. Another element of interviewing to consider is to invite new ideas and information; instead of lecturing patients about taking medications on time or telling them they need to stop doing drugs—simply asking a patient “would you like to know more about how we can help you stop using opioids?” respects their choice but can also spark new ideas for them to consider. Singh: Adaptability is another key component to exceling patient care in street medicine. Like, performing physical exams on park benches or in the back of a minivan. Always doing good with our care but also respecting their autonomy is crucial in building a trust that these patients once lost with our system. Wase: Each patient has their own timeline, but we as providers should always assure them that our door is always open for them when they are ready to seek care. Conclusion.Wase: So, to wrap up — Street Medicine and harm reduction remind us that healthcare isn't just about hospitals and clinics. It's about relationships, trust, and dignity.Every patient deserves care, no matter where they sleep at night.If you're a resident or student listening, I encourage you to seek out these experiences — volunteer with Street Medicine teams, learn from harm reduction workers, and let it shape how you practice medicine. Thank you for listening to this episode of the Rio Bravo qWeek podcast. I'm Mohammed — and I hope this conversation inspires you to meet patients where they are and walk with them on their journey to health.Dr. Singh: If you liked this episode, share it with a friend or a colleague. This is Dr. Singh, signing off.Even without trying, every night you go to bed a little wiser. Thanks for listening to Rio Bravo qWeek Podcast. We want to hear from you, send us an email at RioBravoqWeek@clinicasierravista.org, or visit our website riobravofmrp.org/qweek. See you next week! _____________________References:Doohan, N.C. “Street Medicine: Creating a ‘Classroom Without Walls' for People Experiencing Homelessness.” PMC – National Library of Medicine, 2019.Hawk, M., et al. “Harm Reduction Principles for Healthcare Settings.” Harm Reduction Journal, vol. 14, no. 1, 2017.Withers, J.S. “Bringing Health Professions Education to Patients on the Streets.” Journal of Ethics, AMA, vol. 23, no. 11, Nov. 2021.“Our Story.” Street Medicine Institute, 2025, www.streetmedicine.org/our-story.“Principles of Harm Reduction.” National Harm Reduction Coalition, 2024, https://harmreduction.org/about-us/principles-of-harm-reduction/.Salisbury-Afshar, Elizabeth, Bryan Gale, and Sarah Mossburg. “Harm Reduction Strategies to Improve Safety for People Who Use Substances.” PSNet, Agency for Healthcare Research & Quality, 30 Oct. 2024.Douglass, A.R. “Exploring the Harm Reduction Paradigm: The Role of Boards in Drug Policy and Practice.” PMC – National Library of Medicine, 2024.Theme song, Works All The Time by Dominik Schwarzer, YouTube ID: CUBDNERZU8HXUHBS, purchased from https://www.premiumbeat.com/.

In this powerful episode of The Tudor Dixon Podcast, Tom Wolf opens up about his devastating descent from middle-class stability into homelessness and opioid addiction. He exposes the growing impact of fentanyl, the failures in America’s addiction recovery system, and the urgent need for reform. Tom shares how accountability and access to real rehabilitation can save lives—and what policymakers must do to combat the homelessness crisis driven by addiction. The Tudor Dixon Podcast is part of the Clay Travis & Buck Sexton Podcast Network. For more visit TudorDixonPodcast.com Learn more about Tom's Mission HERESee omnystudio.com/listener for privacy information.

Send us a textIn this episode I talk to Dr Gabriel Caluzzi about drink spiking, methanol poisoning & young people's drinking. Dr Caluzzi is a Research Fellow at the Centre for Alcohol Policy Research at La Trobe University. His interests include youth and gendered drinking practices, and he recently co-authored the book “Young People, Alcohol, and Risk: A Culture of Caution”.For further reading on drink spiking, see:Burrell A, Woodhams J, Gregory P, et al. Spiking prevalence and motivation: A review of the literature: National Crime Agency, 2023.Caluzzi G, Wilson I, Riordan B, et al. Alcohol and legitimate victimhood: Analysing Reddit posts to understand perceptions of alcohol's role in drink spiking and sexual violence. International Journal of Drug Policy 2025;138:104743. doi: 10.1016/j.drugpo.2025.104743For further reading on youth drinking, see:Vashishtha R, Pennay A, Dietze P, et al. Trends in Adolescent Drinking Across 39 High-Income Countries: Exploring the Timing and Magnitude of Decline. European Journal of Public Health 2020:1-8. doi: 10.1093/eurpub/ckaa193Caluzzi G, Livingston M, Holmes J, et al. Declining drinking among adolescents: Are we seeing a denormalisation of drinking and a normalisation of non-drinking? Addiction 2022;117(5):1204-12. doi: https://doi.org/10.1111/add.15611 Support the showIf you are interested in one-to-one support for your drinking with Dr James Morris, contact him at DrJamesMorris.com For more episodes visit https://alcoholpodcast.buzzsprout.com/Follow us at @alcoholpodcast on X and Instagram

At September's Union of BC Municipalities convention, Premier David Eby announced that 100 new involuntary care beds would open in the province. The new beds will be shared between Surrey and Prince George, adding to 18 long-term involuntary care beds announced for Maple Ridge in June. While city councillors in the two municipalities welcomed the move, it has been broadly criticized by drug policy researchers. We speak with Kora DeBeck, Distinguished Professor of Substance Use and Drug Policy in the School of Public Policy at Simon Fraser University and research scientist with the BC Centre on Substance Use.

Since late August, the Trump administration has sent a flotilla of U.S. warships to the southern Caribbean, in the largest naval display in the region in decades. On September 2, a U.S. drone strike sank a small boat near the Venezuelan coast, killing as many as eleven civilians. Administration officials allege the vessel carried cocaine, but have presented no evidence. In this WOLA Podcast episode, Adam Isacson speaks with Laura Dib, Director for Venezuela, and John Walsh, Director for Drug Policy and the Andes, about the shockwaves from this escalation, both region-wide and especially in Venezuela. An Extreme New Military Stance: Seven warships and up to 7,000 personnel now patrol Caribbean waters near Venezuela. A lethal strike on September 2 marks, as Walsh calls it, “a radical departure” from decades of U.S. maritime drug-interdiction practice. Serious Legal and Human-Rights Implications: U.S. law authorizes interdiction of illegal drugs, not summary execution. “There's a word in English for an act like this,” Walsh warns. “That word is murder.” International law allows the use of force only in self-defense or with the approval of the UN Security Council—neither applies. U.S. law and policy, too, prohibit the use of lethal force on civilians without a self-defense justification. That is so even if those civilians are labeled “terrorists,” if there is no link to the September 11, 2001 attacks, and no explicit congressional authorization for the use of force. The Venezuela Context: After fraudulent July 2024 elections, Nicolás Maduro governs without legitimacy, with widespread persecution and what Dib calls “reasons to believe that crimes against humanity have been committed.” There is also a clear connection between large-scale corruption and the complex humanitarian emergency in which the country is immersed. Criminal economies flourish in a regime of state-embedded drug trafficking, but Venezuela is not the busiest route for U.S.-bound cocaine. The Reality of the U.S. Drug Overdose Crisis: The U.S. overdose emergency is driven by fentanyl and other opioids “that come almost entirely through Mexico,” Walsh notes, “with zero to do with anything in the Caribbean.” At least as of 2022, 80 percent of cocaine also transits the Pacific route via Central America and Mexico, not the Caribbean. U.S. Political Calculations: Trump administration officials boast of the strike and hint at more. They frame Venezuela as a “narco-terror” threat while simultaneously maintaining oil licenses, cooperating on deportations, and even meeting with Maduro earlier this year. Walsh warns the move feeds a domestic narrative of an “invasion” of migrants and organized crime groups to justify domestic use of emergency powers. Regional and Global Fallout: Some Latin American governments show “striking silence,” Dib observes, torn between defending sovereignty and condemning Maduro's abuses. The OAS and UN have issued only mild calls for de-escalation, reflecting both U.S. pressure and Venezuela's authoritarian reality. Both guests outline alternatives: Cut the Financial Lifelines: Dib calls for re-establishing the Justice Department's Kleptocracy Asset Recovery Initiative to seize billions in stolen Venezuelan assets. The U.S. government should coordinate more closely with Europe and Latin America to track the proceeds of corruption and undermine the economic pillar of support for authoritarian governments with connections to illicit economies. Support Civil Society and Rule of Law: It is urgent to restore programming previously administered by USAID that sustains independent journalism and human-rights groups now operating under threat, and to use universal-jurisdiction statutes to prosecute Venezuelan officials responsible for torture or other grave abuses. Address U.S. Drug Demand at Home: Expand and strengthen harm-reduction and treatment—naloxone distribution, methadone access—that have begun to lower overdose deaths. Reject the false promise of militarized interdiction that decades of evidence show to be ineffective and costly. As Isacson sums up, “From overdose prevention to supporting civil society in Venezuela to curbing illicit financial flows…the administration is taking key tools out of its toolbox” while swinging a military sledgehammer. Other resources from WOLA: September 8 - Q&A: Tension between Venezuela and the United States: between truth and theater September 3 - Lethal U.S. military strike on alleged drug traffickers sets a dangerous precedent in the “war on drugs” August 14 - One year since the presidential election of July 28, 2024: the Venezuelan crisis August 13 - Five Reasons Why Trump's Anti-Cartel Military Plan Will Fail

Health Affairs' Jeff Byers welcomes Andrew Twinamatsiko of O'Neill Institute for National and Global Health Law back to the program to discuss pharmacy benefit managers, the laws around PBMs, the statutes in place from the Express Scripts Inc. v. Richmond case, and more.Next week, Health Affairs will be releasing a new theme issue focusing on insights from the opioids crisis. Subscribe to the journal to never miss out on an upcoming issue.Join us for these upcoming events:9/3: Theme Issue Briefing: Insights About The Opioid Crisis (FREE TO ALL)9/17: Lunch & Learn: The Current Opioids Policy Landscape & What's Ahead (FREE TO ALL)Related Articles:Arkansas PBM law could spur lookalike restrictions (Axios)Express Scripts Inc et al v. Richmond et al (Judicial Publications)PBM lobby sues Arkansas over law requiring drug middlemen to sell pharmacies (Healthcare Dive)

On this week's Headlines edition of the podcast, we start by summing up the most relevant details from the massive budget bill recently passed by Congress and signed by President Trump. We also discuss The Imprint's recent reporting on youth who enter foster care due to their behavioral health needs, and not because of abuse or neglect, and describe the new policies in New Mexico around removal of newborns who test positive for certain drugs. Reading RoomWhite House Watchhttps://imprintnews.org/special-series/white-house-watchThe Trump Admin is Withholding over $6 Billion in Education Grants for Schoolshttps://www.npr.org/2025/07/01/nx-s1-5453457/trump-school-funding-grants Trump Freezes Grant Funding, Upending School Budgetshttps://edsource.org/2025/california-education-federal-funding-cuts-teachers-english-learners/735665When Minnesota ParentsGive Up Their Kids to Foster Care: An Imprint Look at a Nationwide Predicamenthttps://imprintnews.org/child-welfare-2/when-minnesota-parents-give-up-their-kids-to-foster-care-an-imprint-look-at-a-nationwide-predicament/261820Michigan Justice Seeks ‘No-fault' Pathway to State Aid for Parents Who Can't Manage Kids' Mental Health Needshttps://imprintnews.org/top-stories/michigan-justice-seeks-no-fault-pathway-to-state-aid-for-parents-who-cant-manage-kids-mental-health-needs/262500Texas Lawmakers Take On Little-Known Pathway Into Foster Care: Parents Seeking Mental Health Treatment for Their Childrenhttps://imprintnews.org/top-stories/texas-lawmakers-take-on-little-known-pathway-into-foster-care-parents-seeking-mental-health-treatment-for-their-children/259701New Mexico Governor Plans to Crack Down on Families with Babies Born Addictedhttps://www.santafenewmexican.com/news/legislature/governor-plans-to-crack-down-on-families-with-babies-born-addicted/article_755e8552-554c-49ed-864f-df14dd1abaf4.html

The Center for Disease Control reports that over 48,000 Americans died from synthetic opioid (or fentanyl) overdoses in 2024. That number dwarfed the number of people who died from psychostimulants like methamphetamine at 29,000. As well as cocaine at 22,000, and other naturally occuring drugs at 8,000. Fentanyl and similar substances have changed the game in drug policy, driving greater lethality and creating geopolitical rifts, as China exports precursors to the drug and Mexican cartels smuggle it across the border. Responsible drug policy is complicated and contentious. Here to explain the conservative approach to this area is Paul Larkin, Senior Legal Research Fellow here at the Heritage Foundation. —More by Paul Larkin: https://www.heritage.org/staff/paul-j-larkinHave thoughts? Let us know at heritageexplains@heritage.org

The Center for Disease Control reports that over 48,000 Americans died from synthetic opioid (or fentanyl) overdoses in 2024. That number dwarfed the number of people who died from psychostimulants like methamphetamine at 29,000. As well as cocaine at 22,000, and other naturally occuring drugs at 8,000. Fentanyl and similar substances have changed the game […]